Literature DB >> 22406145

Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation.

Tze-Fan Chao1, Kibos Ambrose, Hsuan-Ming Tsao, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Kazuyoshi Suenari, Cheng-Hung Li, Beny Hartono, Hung-Yu Chang, Tsu-Juey Wu, Shih-Ann Chen.   

Abstract

BACKGROUND: Catheter ablation of paroxysmal atrial fibrillation has been performed for more than 10 years. However, data about the long-term results were limited.
OBJECTIVES: To evaluate the long-tem efficacy following paroxysmal atrial fibrillation ablation and to investigate whether there were different patterns of recurrences in patients with different CHADS(2) scores.
METHODS: A total of 238 patients with paroxysmal atrial fibrillation who received a catheter ablation from 2004 to 2007 were enrolled. Free of recurrence was defined as the absence of atrial arrhythmias without using any antiarrhythmic agents after ablation.
RESULTS: There were 121 patients (50.8%) suffering from recurrences after the first ablation procedure during a median follow-up period of 5 years. The CHADS(2) score and left atrial diameter were significant predictors of recurrences in the multivariate analysis. Different patterns of recurrence were observed in different groups of patients categorized on the base of CHADS(2) score. Among patients with a CHADS(2) score of ≥3 without recurrences at 2 years postablation, 63.6% experienced episodes of arrhythmias during the subsequent follow-up period. In contrast, in patients with a CHADS(2) score of 0 without recurrences at 2 years postablation, the future recurrence rate was only 2.7%.
CONCLUSIONS: After a successful ablation, recurrences may continue to occur without reaching a plateau during the long-term follow-up, especially in patients with a high CHADS(2) score. The optimal follow-up strategy may differ and should be individualized for patients with different scores.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22406145     DOI: 10.1016/j.hrthm.2012.03.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  18 in total

Review 1.  Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Falco Kosich; Katja Schumacher; Tatjana Potpara; Gregory Y Lip; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2019-01-14       Impact factor: 2.882

Review 2.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

3.  Safety of catheter ablation for atrial fibrillation in patients with intracranial hemorrhage.

Authors:  H Lin; S-N Li; R Bai; S-N Wen; N Liu; D-Y Long; R-H Yu; R-B Tang; C-H Sang; X Du; J-Z Dong; C-S Ma
Journal:  Herz       Date:  2017-03-17       Impact factor: 1.443

Review 4.  MRI use for atrial tissue characterization in arrhythmias and for EP procedure guidance.

Authors:  Ehud J Schmidt; Henry R Halperin
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-07       Impact factor: 2.357

5.  Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.

Authors:  Jana Mareike Nührich; Karl-Heinz Kuck; Dietrich Andresen; Daniel Steven; Stefan G Spitzer; Ellen Hoffmann; Burghard Schumacher; Lars Eckardt; Johannes Brachmann; Thorsten Lewalter; Matthias Hochadel; Jochen Senges; Stephan Willems; Boris A Hoffmann
Journal:  Clin Res Cardiol       Date:  2014-12-24       Impact factor: 5.460

Review 6.  Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?

Authors:  Tze-Fan Chao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Fa-Po Chung; Jo-Nan Liao; Shih-Ann Chen
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

7.  Is It Safe (and When) to Stop Oral Anticoagulation After Ablation for Atrial fibrillation? (Do We Have Enough Evidence to Solve the Dilemma?).

Authors:  José Luis Merino; Juan Tamargo
Journal:  Cardiovasc Drugs Ther       Date:  2021-09-07       Impact factor: 3.727

Review 8.  Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.

Authors:  Faisal F Syed; Hakan Oral
Journal:  J Atr Fibrillation       Date:  2015-12-31

9.  Closed Chest Convergent Epicardial-Endocardial Ablation of Non-paroxysmal Atrial Fibrillation - A Case Series and Literature Review.

Authors:  Amit J Thosani; Paul Gerczuk; Emerson Liu; William Belden; Robert Moraca
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04

10.  The Convergent Procedure - A Standardised and Anatomic Approach Addresses the Clinical and Economic Unmet Needs of the Persistent Atrial Fibrillation Population.

Authors:  James McKinnie
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.